Uncategorized
Health economic analysis shows high return on investment from glaucoma treatment
PRAGUE — Treating glaucoma saves sight and money and should be seen as an investment rather than a burden, according to one speaker here at the European Glaucoma Society Congress. “We could certainly save money by reducing visual field test frequency, decreasing the number of patient visits or using cheaper drugs. However, what we should think of is not just cost, but the balance between cost and what we get in return for it,” Carroll Webers, MD, said.